TP53 and erythroleukemia: Rapamycin-resistant mTORC1 selectively, but not exclusively, regulates 4E-BP1 hyperphosphorylation, which is also specifically targeted by P53 activation in murine erythroleukemia cells,27 further supporting the idea that it is a distinct complex.